Related Experiment Videos
Factors predicting development of renal involvement in progressive systemic sclerosis
The American Journal of Medicine
|May 1, 1984
Summary
Scleroderma renal crisis, a complication of diffuse systemic sclerosis, often occurs early in the disease. Rapid skin thickening, anemia, and heart issues signal a high risk for this serious kidney complication.
Area of Science:
- Nephrology
- Rheumatology
- Dermatology
Background:
- Progressive systemic sclerosis (PSS) is an autoimmune disease characterized by widespread connective tissue hardening.
- Scleroderma renal crisis (SRC) is a severe complication affecting the kidneys in patients with PSS.
- Early identification of risk factors for SRC is crucial for timely intervention and improved patient outcomes.
Purpose of the Study:
- To identify clinical and laboratory predictors of scleroderma renal crisis in patients with PSS.
- To compare characteristics of PSS patients with and without renal involvement.
- To determine if early disease progression markers indicate a higher risk for SRC.
Main Methods:
- Retrospective analysis of 60 patients with PSS and renal involvement (SRC) from 1972-1982.
- Comparison of patients with SRC (n=36) versus PSS patients without renal involvement (n=212).
- Analysis of clinical, laboratory, and serologic data, focusing on the period preceding renal crisis onset.
Main Results:
- SRC occurred early in PSS (mean 3.2 years post-onset).
- Patients with SRC had shorter disease duration at evaluation and less frequent digital pitting scars.
- Rapid skin thickening, anemia, and cardiac involvement (pericardial effusion, congestive heart failure) preceded SRC in a significant subset of patients.
Conclusions:
- Diffuse scleroderma patients with rapid early skin progression, anemia, or cardiac issues are at high risk for scleroderma renal crisis.
- Early disease markers, beyond duration and digital scars, are important for identifying patients susceptible to SRC.
- This study highlights the need for vigilant monitoring for renal complications in specific PSS patient subgroups.